Minoxidil
•Last Updated: September 28 2022
Commonly known as Rogaine (brand name), Minoxidil is a topical application that enhances hair growth. Less effective in Male Pattern Baldness than 'Bald patches', Minoxidil is the most commonly used topical hair growth compound.
Minoxidil is most often used for
Last Updated: September 28 2022
Note that Minoxidil is also known as:
- Rogaine
Usage of minoxidil as a topical formulation in the concentration range of 2-5%, with 5% being slightly better than 2% at promoting hair growth. Although oral supplementation technically aids hair growth, it is not advised due to possible complications with blood pressure.
What works and what doesn't?
Unlock the full potential of Examine
Latest ResearchRead all studies
1.^Randall VAHormonal regulation of hair follicles exhibits a biological paradoxSemin Cell Dev Biol.(2007 Apr)
3.^Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA, Washenik KPsychological effect, pathophysiology, and management of androgenetic alopecia in menMayo Clin Proc.(2005 Oct)
4.^Shorter K, Farjo NP, Picksley SM, Randall VAHuman hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidilFASEB J.(2008 Jun)
5.^Li M, Marubayashi A, Nakaya Y, Fukui K, Arase SMinoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidilJ Invest Dermatol.(2001 Dec)
6.^Wester RC, Maibach HI, Guy RH, Novak EMinoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmographyJ Invest Dermatol.(1984 May)
7.^Namazi MR, Handjani FAn immunologic mechanism for the therapeutic efficacy of minoxidil in alopecia areataJ Drugs Dermatol.(2004 Mar-Apr)
8.^Michelet JF, Commo S, Billoni N, Mahé YF, Bernard BAActivation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effectJ Invest Dermatol.(1997 Feb)
9.^Wolf R, Matz H, Zalish M, Pollack A, Orion EProstaglandin analogs for hair growth: great expectationsDermatol Online J.(2003 Aug)
10.^Namazi MRNitric oxide donors as potential additions to anti-alopecia areata armamentariumInflamm Res.(2003 Jun)
11.^Mapar MA, Omidian MIs topical minoxidil solution effective on androgenetic alopecia in routine daily practiceJ Dermatolog Treat.(2007)
12.^Olsen EA, Weiner MS, Amara IA, DeLong ERFive-year follow-up of men with androgenetic alopecia treated with topical minoxidilJ Am Acad Dermatol.(1990 Apr)
13.^Olsen EA, DeLong ER, Weiner MSLong-term follow-up of men with male pattern baldness treated with topical minoxidilJ Am Acad Dermatol.(1987 Mar)
14.^Tsuboi R, Arano O, Nishikawa T, Yamada H, Katsuoka KRandomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese menJ Dermatol.(2009 Aug)
15.^Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels NA randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in womenJ Am Acad Dermatol.(2011 Dec)
16.^Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut BA multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in menJ Am Acad Dermatol.(2007 Nov)
17.^Arca E, Açikgöz G, Taştan HB, Köse O, Kurumlu ZAn open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopeciaDermatology.(2004)
18.^Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MDA randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossJ Am Acad Dermatol.(2004 Apr)
19.^Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJA randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in menJ Am Acad Dermatol.(2002 Sep)
20.^Price VH, Menefee E, Strauss PCChanges in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatmentJ Am Acad Dermatol.(1999 Nov)
21.^Olsen EA, Weiner MSTopical minoxidil in male pattern baldness: effects of discontinuation of treatmentJ Am Acad Dermatol.(1987 Jul)
22.^Tosti A, Camacho-Martinez F, Dawber RManagement of androgenetic alopeciaJ Eur Acad Dermatol Venereol.(1999 May)
23.^Ferry JJ, Forbes KK, VanderLugt JT, Szpunar GJInfluence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solutionClin Pharmacol Ther.(1990 Apr)
24.^Bazzano GS, Terezakis N, Galen WTopical tretinoin for hair growth promotionJ Am Acad Dermatol.(1986 Oct)
25.^Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HCEfficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trialAm J Clin Dermatol.(2007)
26.^Berger RS, Fu JL, Smiles KA, Turner CB, Schnell BM, Werchowski KM, Lammers KMThe effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trialBr J Dermatol.(2003 Aug)
27.^Hugo Perez BSKetocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in menMed Hypotheses.(2004)
28.^Khandpur S, Suman M, Reddy BSComparative efficacy of various treatment regimens for androgenetic alopecia in menJ Dermatol.(2002 Aug)
29.^Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GEKetoconazole shampoo: effect of long-term use in androgenic alopeciaDermatology.(1998)
30.^van Zuuren EJ, Fedorowicz Z, Carter B, Andriolo RB, Schoones JInterventions for female pattern hair lossCochrane Database Syst Rev.(2012 May 16)
31.^van Zuuren EJ, Fedorowicz Z, Carter BEvidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic reviewBr J Dermatol.(2012 Oct 5)
Primary Use